Alto&#8217;s funding boost for depression drug trials could accelerate innovative 
treatments, potentially transforming neuropsychiatric care landscapes.
The post Alto Neuroscience stock rises as firm secures $120M to advance 
depression drug appeared first on Crypto Briefing.

Alto Neuroscience stock rises as firm secures $120M to advance depression drug

Crypto’s innovation dazzles but fragments liquidity. Institutions demand 
boring reliability over novel protocols to move real capital at scale.

Crypto needs to put on a business suit

Strategy bought 22,337 Bitcoin for $1.57 billion last week, lifting total 
holdings to 761,068 BTC as it funds purchases through record sales of its STRC 
preferred stock.

Strategy buys $1.6B in Bitcoin as holdings surpass 761,000 BTC

Crypto investment products recorded $1.06 billion in inflows last week, even 
as geopolitical stress tied to tensions in the Middle East continued to weigh 
on broader financial markets. Per a CoinShares report published Monday, crypto 
investor reaction to tensions in…

Crypto funds draw $1.06B in inflows for third week as Bitcoin leads demand

Hana Financial Group will collaborate with Standard Chartered on digital 
assets following its stablecoin partnership with USDC issuer Circle earlier in 
March.

Cryptocurrency price in UAH